Recently, Prof. Pratibha, a pancreatic cancer patient from India, told the reporter with great excitement, “NanoKnife therapy made me able to walk normally again” after she underwent NanoKnife therapy on pancreatic cancer at Guangzhou Fuda Cancer Hospital.
Several months ago, Prof. Pratibha was undergoing a life or death test. Back then, she looked totally different from the way she is now as she looks like a noble woman who is dignified, talkative, beautiful and smart now.
A photo of Prof. Pratibha Rajgopal (R 3), her family member and medical workers
Prof. Pratibha was diagnosed with pancreatic cancer two months ago at local hospital due to discomfort in abdomen. Doctor told her family member that the chance of treatment was very low. The best chance would be about 10%. Prof. Pratibha was desperate to hear the news. She underwent one cycle of chemotherapy in local hospital, the side effects of which made her suffer a lot.
Her son, who is working in America, searched for the most renowned cancer hospital in the world online, hoping that his mother could be treated. After searching on the internet for a while, he located Guangzhou Fuda Cancer Hospital in China. Compared with other international cancer hospitals, he believed that the argon-helium cryosurgery, iodine seeds implantation therapy and NanoKnife therapy that FUDA has can deliver good curative effects for pancreatic cancer patients. Among all the therapies, the latest treatment NanoKnife therapy that FUDA has introduced delivers remarkable curative effects for pancreatic cancer, which has become widely recognized in the world. Moreover, the concept of coexisting with cancer proposed by Professor Xu Kecheng coincides with his view of cancer.
Prof. Pratibha was admitted into Guangzhou Fuda Cancer Hospital in the company of her sister and the other son on August 26, 2015. The medial team led by President NIu Lizhi arranged a series examinations for her on August 27. Diagnosis upon admission was Stage III T4N0M0 pancreatic cancer, II type diabetes and hypertension.
The patient together with her family members unanimously requested to receive NanoKnife therapy. In order to choose the best treatment for her, President Niu Lizhi and other experts, after discussion, decided to give her NanoKnife therapy combined with “3C+P” treatment mode. On August 28, she was given combined immunotherapy for cancer (CIC)--one therapy in the “3C+P” treatment mode--in order to improve her immunity.
After her condition became stable, Chief President Xu Kecheng, President Niu Lizhi and other experts had a penal discussion about her further treatment, after which they decided to give her NanoKnife therapy. On August 31, the medical team led by Niu Lizhi performed NanoKnife therapy on pancreatic cancer for her. The procedure went smoothly and the patient’s postoperative recovery was great. On September 12, Prof. Pratibha was discharged and went back to India.
Prof. Pratibha said, “coming to Fuda Cancer Hospital for treatment is the best decision that i have ever made in my life and has also given me the opportunity to better know about Chinese doctors, especially such excellent medical experts as Chief President Xu Kecheng and President Niu Lizhi. Under their leadership, medical workers at Fuda have developed a harmonious relationship with patients. During my hospitalization, i am deeply touched by the comprehensive treatment i have received and also the careful nursing delivered by nurses. Guangzhou Fuda Cancer Hospital has proven itself to be an international specialized cancer hospital.”
Three months ago, Fuda Cancer Hospital became the first to have introduced NanoKnife therapy (Irreversible Electroporation) in Mainland of China. Medical workers at Fuda have successfully performed NanoKnife therapy for over 40 pancreatic cancer and liver cancer patients, after which the curative effect was remarkable.
